Lv6
2168 积分 2021-03-24 加入
Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease
8小时前
待确认
Vedolizumab for the Treatment of Active Ulcerative Colitis: A Randomized Controlled Phase 2 Dose-ranging Study
1天前
待确认
TL1A: A model for a precision medicine approach in the treatment of Crohn’s disease and Ulcerative colitis
1天前
待确认
CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types
15天前
已完结
Cystic fibrosis: scoring system with thin-section CT
15天前
已完结
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
1个月前
已完结
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
1个月前
已完结
Anti-IL5 and anti-IL5Rα therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series
1个月前
已完结
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies
1个月前
已完结
Bronchiectasis and inhaled tobramycin: A literature review
1个月前
已完结
皖公网安备34019202002308
